|
Industry
As the medical device and pharmaceutical industries continue to merge and new products are revolutionizing the healthcare industry, many pharmaceutical companies are partnering with medical device and biologic firms to formulate “combination products” – or those comprised of two or more regulated components (i.e. drug + device, drug + biologic, etc.) Many experts agree these combination products are the future of the medical industry.
This is a growing market with great potential. The global market for drug-device combinations was valued at $5.4 billion in 2004. Experts agree that the market is growing rapidly between 10% and 14% per year. Cardiovascular applications currently dominate, with 88% of the market. Other fast-growing segments include coverings, bone growth factors, steroid-eluting electrodes, closed-loop glucose monitoring insulin pumps, inhalation devices and transdermal delivery systems.
With the convergence of the medical device, pharmaceutical, and biologic industries, there are now a wealth of resources available and PharmaMedDevice is helping to to bring them to you.
Click here for -> Combination Products / FDA Guidances
Click here for -> Converging Industry Newsfeed
Click here for -> Industry Facts and Statistics
Click here for -> Industry Links and Resources
Click here for -> Complimentary Combination Products and Medical
Device Industry Podcasts
Click here for -> Medical Device and Combination Products on
Demand Webcasts
Click here for -> Converging Technologies Industry Blog
|
